Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New adenovirus vectors for protein production and gene transfer.
Massie B, Mosser DD, Koutroumanis M, Vitté-Mony I, Lamoureux L, Couture F, Paquet L, Guilbault C, Dionne J, Chahla D, Jolicoeur P, Langelier Y. Massie B, et al. Among authors: dionne j. Cytotechnology. 1998 Nov;28(1-3):53-64. doi: 10.1023/A:1008013211222. Cytotechnology. 1998. PMID: 19003407 Free PMC article.
Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma.
Jamal R, Lapointe R, Cocolakis E, Thébault P, Kazemi S, Friedmann JE, Dionne J, Cailhier JF, Bélanger K, Ayoub JP, Le H, Lambert C, El-Hajjar J, van Kempen LC, Spatz A, Miller WH Jr. Jamal R, et al. Among authors: dionne j. J Immunother Cancer. 2017 Nov 21;5(1):83. doi: 10.1186/s40425-017-0290-x. J Immunother Cancer. 2017. PMID: 29157311 Free PMC article. Clinical Trial.
Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115.
Maroun JA, Belanger K, Seymour L, Matthews S, Roach J, Dionne J, Soulieres D, Stewart D, Goel R, Charpentier D, Goss G, Tomiak E, Yau J, Jimeno J, Chiritescu G; National Cancer Institute of Canada Clinical Trials Group. Maroun JA, et al. Among authors: dionne j. Ann Oncol. 2006 Sep;17(9):1371-8. doi: 10.1093/annonc/mdl165. Ann Oncol. 2006. PMID: 16966366 Free article. Clinical Trial.
DoxyPEP to Prevent Bacterial STIs-Ready for Prime Time?
Marrazzo JM, Dionne JA. Marrazzo JM, et al. Among authors: dionne ja. JAMA Intern Med. 2025 Jan 6. doi: 10.1001/jamainternmed.2024.7165. Online ahead of print. JAMA Intern Med. 2025. PMID: 39761021 No abstract available.
Upconverting microgauges reveal intraluminal force dynamics in vivo.
Casar JR, McLellan CA, Shi C, Stiber A, Lay A, Siefe C, Parakh A, Gaerlan M, Gu XW, Goodman MB, Dionne JA. Casar JR, et al. Among authors: dionne ja. Nature. 2025 Jan;637(8044):76-83. doi: 10.1038/s41586-024-08331-x. Epub 2025 Jan 1. Nature. 2025. PMID: 39743609
Enrolment patterns in a randomized controlled trial of probiotics in critically ill patients: a retrospective analysis of the PROSPECT trial.
Takaoka A, Johnstone J, Lauzier F, Heels-Ansdell D, Davis M, Zytaruk N, Duan E, Dionne J, Saunders L, Arabi YM, Marshall J, Thabane L, Clarke F, Hand L, Masse MH, Rochwerg B, McIntyre L, Girard M, Freitag A, Karachi T, Cook DJ; PROSPECT Investigators; Canadian Critical Care Trials Group. Takaoka A, et al. Among authors: dionne j. Trials. 2024 Dec 27;25(1):851. doi: 10.1186/s13063-024-08701-w. Trials. 2024. PMID: 39731129 Free PMC article. Clinical Trial.
307 results